[Webinar held on 5/17] <Peaceful compliance measures commentary series 2nd> Site of whistleblowing response
Today, how to ensure the effectiveness of the whistleblowing system is one of the most annoying challenges for many companies.In addition, with the imminent enforcement of the revised Whistleblower Protection Act, which includes the obligation to improve the whistleblower system, many companies may be busy with the operation of the new whistleblower system.
Therefore, this time, we would like to invite Mr. Daisuke Fukamizu, a partner of Nagashima Ohno & Tsunematsu Law Office, to introduce several important issues that are frequently faced in the field of dealing with whistleblowing cases.Furthermore, in the lecture, you will be asked to consider and explain important issues from the practical point of view of Attorney Fukamizu.
* This seminar is the second in a series of three seminars in which Mr. Fukamizu, a lawyer from Nagashima Ohno & Tsunematsu Law Office, explains peacetime compliance measures. Even those who have not attended the first lecture can participate, so please apply.
◆ Title: <Peaceful Compliance Measures Explanation Series 2nd> Site for whistleblowing
◆ Date: July 2022, 5 (Tuesday) 17: 10-00: 11
◆ Webinar type: Zoom Webinar
ALB under 40 Asia Outstanding Legal Professionals 40 (2019)
Legal 500 Asia Pacific Next Generation Lawyers (2020)
ALB Young Lawyer of the Year (2020)
FRONTEO Inc. Director / AI Solution Business Management and President's Office Manager
Mari Yamamoto
After joining an advertising agency, she was enrolled in a risk management company.Launch the mental health care business, execute business plans, product development, marketing, and sales strategies, and lead to the top market share in the industry. In 2014, she became a director of the company and was listed on the First Section of the Tokyo Stock Exchange in 2017.
Joined FRONTEO Inc. in December 2018 and became a director in 12, managing and directing the entire AI solution business.
In the life science AI business, we will promote development in the digital health field such as diagnostic support and disease prediction using the artificial intelligence engine "Concept Encoder", and also in the drug discovery field, a drug discovery support AI system that supports speeding up the discovery of candidate compounds. To challenge new areas in life science.
In the business intelligence business, he uses the artificial intelligence engine "KIBIT" to direct the DX promotion of companies.We will also develop solutions that utilize AI in the field of economic security to support governments, government agencies, and companies.
Articles in the same category
[Real Seminar on June 6th] Initial Response and Legal Actions in Case of Trade Secret Leakage ~Collaboration between Departments and Digital Forensics~
[June 6nd Webinar] How Japanese Companies Gain an Advantage in US Lawsuits. -How to reduce the advantages and disadvantages unique to Japanese companies-
[6/8 Webinar] Latest US Department of Justice (DOJ) corporate crackdown policy and its impact on Japanese companies
[Webinar held on June 6] Comparative study of what companies are required to do regarding business and human rights and the actual efforts of each company -Aiming for further respect for human rights and improvement of corporate value-
[Held on May 5th!25nd Economic Security Study Group] "New Phase of M&A for Japan and China Money, Detailed Explanation with Actual Cases" The whole story of how a Chinese entrepreneur who escaped from the Xi Jinping regime set up a takeover in Japan
[Event held on May 5] "Initial response and legal measures in the event of trade secret leaks" by retirees taking out information ~Interdepartmental collaboration and digital forensics~
[May 5th Webinar] Introduction of utilization cases of disease network analysis by natural language processing AI
[May 5th Webinar] Protecting Japanese Companies from U.S. Regulators -- "Best Measures" and "Latest Trends"
[5/23 5th Fraud Countermeasures Study Group] Hypotheses and countermeasures based on the ranking of "100 companies with a large number of whistleblowing cases" Fraud risks that cannot be measured only by the number of whistleblowing reports Former editor-in-chief of Toyo Keizai "CSR Company Directory" Detailed explanation
Commonly viewed articles
Chugai Pharmaceutical Co., Ltd. has been posted as an introductory user.
FRONTEO's finance in NHK Close-up Gendai + "How to protect your assets? -Prescription for the ultra-low interest rate era-" broadcast on 10/30 ...
Comprehensive support for marriage activities using artificial intelligence KIBIT at the NHK special "Artificial Intelligence Angel or Devil 9" broadcast on 15/2018 ...
FRONTEO has been entrusted with an empirical research project utilizing artificial intelligence in the 30 JPO open call for participants project, following last year.
